Skip to content

Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care

A Hybrid Type III Implementation Trial Testing Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05241990
Enrollment
300
Registered
2022-02-16
Start date
2023-02-15
Completion date
2026-09-30
Last updated
2025-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hiv, Alcohol Use, Unspecified

Brief summary

Despite availability of evidence-based alcohol reduction interventions (EBI), unhealthy alcohol use remains a barrier to HIV medication adherence, viral suppression and retention in HIV care and consequently HIV treatment as prevention (TASP). Guided by complementary implementation and evaluation frameworks-the Consolidated Framework for Implementation Research (CFIR) and RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance), The investigators will conduct a Hybrid Type 3 effectiveness-implementation evaluating implementation trial testing whether practice facilitation, an evidence-based multifaceted implementation strategy increases reach, adoption, implementation, and maintenance of stepped care for unhealthy alcohol use in three Center for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) HIV clinics located in Boston, San Diego, and Chapel Hill. The investigators will secondarily test whether practice facilitation is associated with decreased unhealthy alcohol use, and improved Antiretroviral Therapy (ART) adherence and viral suppression at the patient level. In practice facilitation, a practice coach will offer tools, resources, hands-on guidance, and content expertise to assist sites in offering a stepped care model of alcohol treatment to patients with unhealthy alcohol use. Stepped care will include brief intervention, cognitive behavioral therapy, and alcohol pharmacotherapy. The practice facilitation intervention will be rolled out sequentially across sites. There will be three phases at each site: pre-implementation planning, implementation with formative evaluation, and post-implementation summative evaluation. Using mixed methods, The investigators specifically propose to meet the following specific aims: (Aim 1) Tailor the practice facilitation intervention to each site using mixed methods (pre-implementation); (Aim 2a) Determine the effects of practice facilitation on implementation of stepped care (primary) and alcohol use and HIV-related outcomes (secondary) using interrupted time series analysis with synthetic controls (summative evaluation); (Aim 2b) Determine the effect of practice facilitation on reach, adoption, and maintenance of evidence-based alcohol treatment using mixed methods (formative evaluation); and (Aim 3) Describe barriers and facilitators to implementation of alcohol-related interventions at each site to describe maintenance and inform widespread sustainable implementation.

Interventions

A practice coach will offer tools, resources, hands-on guidance, and content expertise to assist sites in offering a stepped care model of alcohol treatment to patients with unhealthy alcohol use.

BEHAVIORALAlcohol Stepped Care

Based on severity of alcohol use, individuals receive brief alcohol intervention delivered in person or by computer, cognitive behavioral therapy by person or computer, or pharmacotherapy for alcohol use disorder

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
University of Washington
CollaboratorOTHER
University of Alabama at Birmingham
CollaboratorOTHER
Fenway Community Health
CollaboratorOTHER
University of North Carolina
CollaboratorOTHER
University of California, San Diego
CollaboratorOTHER
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Clinic Staff * Age \> 18 years old * Confirmed to be clinic staff (clinical or administrative roles). * English speaking * Cognitively able to complete required survey or interview activities.

Exclusion criteria

Clinic Staff * Unable to speak English Inclusion Criteria, Patients * Confirmed to be a person with HIV (PWH) receiving HIV care and participating in CNICS at one of the three clinic sites * Scoring AUDIT-C ≥3 for women or ≥4 for men, transgender women or men indicating unhealthy alcohol use. * Age ≥ 18 years old. * English speaking. * Cognitively able to participate in stepped care for unhealthy alcohol use.

Design outcomes

Primary

MeasureTime frameDescription
Implementation as assessed by the percent of patients receiving an alcohol intervention12 monthsPercent of patients receiving an alcohol intervention since their last visit among all eligible individuals.

Secondary

MeasureTime frameDescription
Change in unhealthy alcohol use as assessed by the Alcohol Use Disorder Identification test-Consumption (AUDIT-C)Baseline and 12 monthsAUDIT-C Score of \<3 in women and \<4 in men indicating reduction to lower risk use
Antiretroviral therapy adherence as assessed by a self report on a visual analog scale12 monthsSelf report of \>90% adherence on visual analog scale with higher scores indicating greater adherence
Viral Suppression as assessed by HIV-RNA copies12 monthsViral Suppression will assessed by HIV-RNA copies. HIV-RNA \<200 copies indicates viral suppression.

Countries

United States

Contacts

Primary ContactJoAnna Mathena
jmathen5@jhmi.edu410-955-9534
Backup ContactGeetanjali Chander
gchande1@jhmi.edu14432872030

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026